Charles River Laboratorie (CRL) Misses Q1 EPS by 3c
Tweet
Share
E-mailGet Alerts CRL Hot Sheet
Price: $288.50 --0%
Revenue Growth %: -4.3%
Financial Fact:
Continuing operations (in dollars per share): 0.79
Today's EPS Names:
BNED, CAN, UNFI, More
Revenue Growth %: -4.3%
Financial Fact:
Continuing operations (in dollars per share): 0.79
Today's EPS Names:
BNED, CAN, UNFI, More
Join SI Premium – FREE
Charles River Laboratorie (NYSE: CRL) reported Q1 EPS of $0.79, $0.03 worse than the analyst estimate of $0.82. Revenue for the quarter came in at $320.4 million versus the consensus estimate of $324 million.
Charles River Laboratorie sees FY2015 EPS of $3.55-$3.65, versus the consensus of $3.60.
For earnings history and earnings-related data on Charles River Laboratorie (CRL) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- EU proposes to curb Airbnb and short-term rentals amid housing shortage
- TD Cowen Reiterates Buy Rating on Boston Scientific (BSX)
- Roth/MKM Downgrades eGain Corporation (EGAN) to Neutral
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
